Validation of Stroke Prognostic Scores: What Do Clinicians Need to Know?

Publisher： Karger

E-ISSN： 1423-0208|41|3-4|219-220

ISSN： 0251-5350

Source： Neuroepidemiology, Vol.41, Iss.3-4, 2013-10, pp. : 219-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Update on heparin: what do we need to know?

By Weitz Daniel   Weitz Jeffrey  

Journal of Thrombosis and Thrombolysis, Vol. 29, Iss. 2, 2010-02 ,pp. : 199-207

Springer Publishing Company

Access to resources Recommend Favorite

Anti-Mllerian hormone (AMH): what do we still need to know?

By La Marca A.   Broekmans F.J.   Volpe A.   Fauser B.C.   Macklon N.S.  

Human Reproduction, Vol. 24, Iss. 9, 2009-09 ,pp. : 2264-2275

Oxford University Press

Access to resources Recommend Favorite

Clinical end points in baroreflex activation therapy: what do we need to know?

By de Leeuw Peter W   Kroon Abraham A  

Expert Review of Cardiovascular Therapy, Vol. 11, Iss. 6, 2013-06 ,pp. : 683-688

Informa Healthcare

Access to resources Recommend Favorite

Substance Misuse and Abuse in Older Adults: What Do We Need to Know to Help?

By  

Generations, Vol. 38, Iss. 3, 2014-09 ,pp. : 53-67

American Society on Aging

Access to resources Recommend Favorite

Editorial (Thematic Issue: The Interplay between TSH and Lipids. What Should Clinicians Know?)

By  

Current Vascular Pharmacology, Vol. 13, Iss. 1, 2015-01 ,pp. : 91-94

Bentham Science Publishers

Access to resources Recommend Favorite